We are live on
!
Find out more
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Portfolio holdings
AUM
$533M
1-Year Est. Return
65.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.21%
1 Year Est. Return
+65.58%
3 Year Est. Return
+141.73%
5 Year Est. Return
+93.46%
10 Year Est. Return
+1,196.58%
AUM
$1.07B
AUM Growth
-$60.5M
(-5.3%)
Cap. Flow
+$64.5M
Cap. Flow
% of AUM
6.03%
Top 10 Holdings %
Top 10 Hldgs %
92.56%
Holding
40
New
12
Increased
2
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$197M |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$46.3M |
| 3 |
Lyell Immunopharma
LYEL
|
+$27M |
| 4 |
LENZ
LENZ Therapeutics
LENZ
|
+$17.5M |
| 5 |
Bolt Biotherapeutics
BOLT
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$99.9M |
| 2 |
Keurig Dr Pepper
KDP
|
+$62M |
| 3 |
QuantumScape Corp
QS
|
+$60.2M |
| 4 |
EAR
Eargo, Inc. Common Stock
EAR
|
+$21.4M |
| 5 |
ALX Oncology
ALXO
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.16% |
| 2 | Consumer Discretionary | 16.22% |
| 3 | Consumer Staples | 8.34% |
| 4 | Financials | 1.75% |
| 5 | Technology | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $334M | 31.16% |
4,981,309
+2,986,856
| +150% | +$197M |
|
2
iShares MSCI EAFE ETF
EFA
$80.2B
| $196M | 18.27% |
2,479,666
| – | – |
|
|
3
QuantumScape Corp
QS
$3.92B
| $174M | 16.22% |
5,934,284
-1,860,458
| -24% | -$60.2M |
|
|
4
Keurig Dr Pepper
KDP
$40.2B
| $89.3M | 8.34% |
2,534,126
-1,737,852
| -41% | -$62M |
|
5
Kodiak Sciences
KOD
$2.72B
| $64.3M | 6.01% |
691,767
| – | – |
|
|
AKYA
6
DELISTED
Akoya BioSciences
AKYA
| $43.4M | 4.05% |
+2,243,775
| New | +$46.3M |
|
|
7
Lyell Immunopharma
LYEL
$347M
| $26.8M | 2.5% |
+82,394
| New | +$27M |
|
8
Butterfly Network
BFLY
$2.52B
| $22.6M | 2.11% |
1,559,008
| – | – |
|
|
LENZ
9
LENZ Therapeutics
LENZ
$158M
| $21.6M | 2.02% |
+100,529
| New | +$17.5M |
|
10
BridgeBio Pharma
BBIO
$16.4B
| $20.2M | 1.89% |
331,283
| – | – |
|
11
Apollo Global Management
APO
$81.9B
| $15.7M | 1.46% |
+252,179
| New | +$14M |
|
|
12
ALX Oncology
ALXO
$278M
| $14.2M | 1.33% |
259,982
-258,840
| -50% | -$15.5M |
|
|
13
Bolt Biotherapeutics
BOLT
$6.63M
| $11.1M | 1.04% |
+35,977
| New | +$14.6M |
|
14
Annexon
ANNX
$873M
| $10.9M | 1.01% |
482,550
| – | – |
|
15
CrowdStrike
CRWD
$226B
| $4.47M | 0.42% |
71,168
| – | – |
|
16
Nautilus Biotechnolgy
NAUT
$114M
| $3.13M | 0.29% |
+309,492
| New | +$3.35M |
|
|
MDNA
17
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $2.9M | 0.27% |
962,932
| – | – |
|
|
LHDX
18
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $2.5M | 0.23% |
376,705
| – | – |
|
19
Doximity
DOCS
$4.45B
| $2.41M | 0.23% |
+41,484
| New | +$2.33M |
|
20
Upstart Holdings
UPST
$2.83B
| $1.7M | 0.16% |
+13,619
| New | +$1.68M |
|
21
Black Stone Minerals
BSM
$3.08B
| $1.59M | 0.15% |
147,852
| – | – |
|
22
Kimbell Royalty Partners
KRP
$1.53B
| $1.43M | 0.13% |
11,638
-100,000
| -90% | -$1.19M |
|
23
DigitalOcean
DOCN
$15.7B
| $1.34M | 0.13% |
+24,196
| New | +$1.04M |
|
24
LegalZoom.com
LZ
$930M
| $1.02M | 0.1% |
+27,056
| New | +$1.02M |
|
25
Affirm
AFRM
$24.6B
| $960K | 0.09% |
14,252
| – | – |
|
Similar funds
LSCM
KI
UFF
TM
HS
BFC
GC
CM
Board of Trustees of The Leland Stanford Junior University's Q2 2021 Portfolio in Review
As of Q2 2021, Board of Trustees of The Leland Stanford Junior University held 40 positions worth $1.07B, down 5.3% from $1.13B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Board of Trustees of The Leland Stanford Junior University deployed $64.5M of net new capital in Q2 2021, opening 12 new positions and adding to 2 existing holdings. Its largest new stake was Akoya BioSciences: 2,243,775 shares worth $43.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $62M trimmed.
- Board of Trustees of The Leland Stanford Junior University's largest Q2 2021 buy was Akoya BioSciences: 2,243,775 shares worth $43.4M.
- Board of Trustees of The Leland Stanford Junior University added most to iShares Core MSCI Emerging Markets ETF in Q2 2021, an estimated $197M increase.
- Board of Trustees of The Leland Stanford Junior University's biggest Q2 2021 reduction was Keurig Dr Pepper, cutting an estimated $62M.
- Board of Trustees of The Leland Stanford Junior University fully exited Snowflake in Q2 2021, selling an estimated $99.9M.
- Board of Trustees of The Leland Stanford Junior University's ten largest holdings make up 93% of its $1.07B portfolio in Q2 2021.
- Board of Trustees of The Leland Stanford Junior University opened 12 new positions and closed 4 in Q2 2021.
- Board of Trustees of The Leland Stanford Junior University's portfolio value fell 5.3% quarter-over-quarter to $1.07B.
Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2021, filed 16 Aug 2021.